| [1] |
Udall M, Rizzo M, Kenny J, Doherty J, Dahm S, et al. 2018. PD-L1 diagnostic tests: a systematic literature review of scoring algorithms and test-validation metrics. Diagnostic Pathology 13(1):12 doi: 10.1186/s13000-018-0689-9 |
| [2] |
Chebib I, Mino-Kenudson M. 2022. PD-L1 immunohistochemistry: Clones, cutoffs, and controversies. Journal of Pathology, Microbiology and Immunology 130(6):295−313 doi: 10.1111/apm.13223 |
| [3] |
Baş Y, Yılmaz B, Güney G, Şahin HHK, Özçerezci T, et al. 2023. Clinicopathological and prognostic significance of PD-L1 expression in colon adenocarcinoma tumor budding. Annals of Diagnostic Pathology 67:152202 doi: 10.1016/j.anndiagpath.2023.152202 |
| [4] |
The United States Food and Drug Administration (FDA). 2024. Premarket approval (PMA): PD-L1 IHC 22C3 PharmDx. 2019. www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P150013s016 |
| [5] |
Baş Y, Yılmaz B, Acar SF, Karadağ İ. 2024. Programmed Cell Death Ligand 1 Expression in CD163+ Tumor-associated Macrophages in Cancer Gland Rupture Microenvironment. Appl Immunohistochem Mol Morphol 32(4):176−82 doi: 10.1097/PAI.0000000000001186 |
| [6] |
Cai J, Qi Q, Qian X, Han J, Zhu X, et al. 2019. The role of PD-1/PD-L1 axis and macrophage in the progression and treatment of cancer. Journal of Cancer Research and Clinical Oncology 145(6):1377−85 doi: 10.1007/s00432-019-02879-2 |
| [7] |
Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, et al. 2014. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 41(1):14−20 doi: 10.1016/j.immuni.2014.06.008 |
| [8] |
Dong L, Chen C, Zhang Y, Guo P, Wang Z, Li J, et al. 2021. The loss of RNA N6-adenosine methyltransferase Mettl14 in tumor-associated macrophages promotes CD8+ T cell dysfunction and tumor growth. Cancer Cell 39(7): 945-957. e10 |
| [9] |
Zhang H, Liu L, Liu J, Dang P, Hu S, et al. 2023. Roles of tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for solid cancers. Molecular Cancer 22(1):58 doi: 10.1186/s12943-023-01725-x |
| [10] |
Arlauckas SP, Garris CS, Kohler RH, Kitaoka M, Cuccarese MF, et al. 2017. In vivo imaging reveals a tumor-associated macrophage-mediated resistance pathway in anti-PD-1 therapy. Science Translational Medicine 9(389):eaal3604 doi: 10.1126/scitranslmed.aal3604 |
| [11] |
Lavin Y, Mortha A, Rahman A, Merad M. 2015. Regulation of macrophage development and function in peripheral tissues. Nature Reviews Immunology 15(12):731−44 doi: 10.1038/nri3920 |
| [12] |
Chung W, Eum HH, Lee HO, Lee KM, Lee HB, et al. 2017. Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer. Nature Communications 8:15081 doi: 10.1038/ncomms15081 |
| [13] |
Wei C, Yang C, Wang S, Shi D, Zhang C, et al. 2019. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis. Molecular Cancer 18(1):64 doi: 10.1186/s12943-019-0976-4 |